KEVIN JONES: Open Payments
NPI 1710524616 · ITHACA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 18 payments from 8 companies in 2025. Trend: 2023 $528 · 2024 $1,316 · 2025 $507
Food & beverage: $487Education: $20
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| QOL Medical, LLC | 2 | $72 |
| ABBVIE INC. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 2 | $20 |
Products named: TREMFYA, Sucraid, ENTYVIO, VOQUEZNA, XELJANZ, DUPIXENT, LINZESS, RINVOQ.
Industry payments across NY — which companies pay providers there.
